Phase 2 Sarcoma of Bone Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
SarcomaSarcoma, SynovialSarcoma,Soft Tissue+6 more
Essen Biotech60 enrolled1 locationNCT07066982
Recruiting
Phase 2
Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma
SarcomaSarcoma,Soft TissueSarcoma of Bone
Shanxi Province Cancer Hospital30 enrolled1 locationNCT06637007
Recruiting
Phase 2Phase 3
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
SarcomaOsteosarcomaSarcoma of Bone+2 more
Blokhin's Russian Cancer Research Center50 enrolled1 locationNCT05057130
Recruiting
Phase 2
PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA)
SarcomaSarcoma,Soft TissueSarcoma of Bone
Ruijin Hospital86 enrolled1 locationNCT06074692